Showing results (61-70 of 628) with videos related to
Sort By:
Pageof 63
Bulletin Du Cancer|January 24, 2007
[Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006]Mélanie Deberne, Florence Huguet, Romuald Le Scodan, et al.Nature Reviews. Clinical Oncology|May 1, 2013
Advanced-stage pancreatic cancer: therapy optionsJens Werner, Stephanie E Combs, Christoph Springfeld, et al.Cancer Metastasis Reviews|October 23, 2012
Targeting the Ras-ERK pathway in pancreatic adenocarcinomaCindy Neuzillet, Pascal Hammel, Annemilaï Tijeras-Raballand, et al.Expert Review of Pharmacoeconomics & Outcomes Research|September 14, 2012
Impact of restricting access to high-cost medications for hepatocellular carcinomaYuk Ting Ma, Daniel H PalmerCancer Metastasis Reviews|August 8, 2015
Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinomaDaniel H Palmer, Phillip J JohnsonBiochemical Pharmacology|August 17, 2024
Overcoming therapy resistance in pancreatic cancer: New insights and future directionsMargarita Espona-Fiedler, Cedric Patthey, Stina Lindblad, et al.Cancer Research|August 4, 2006
Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinasesChristoph Springfeld, Veronika von Messling, Marie Frenzke, et al.Best Practice & Research. Clinical Gastroenterology|March 22, 2006
The inherited genetics of pancreatic cancer and prospects for secondary screeningLouis J Vitone, William Greenhalf, Christopher D McFaul, et al.Chinese Clinical Oncology|January 14, 2025
Tumour plasticity and tumour microenvironment interactions as potential immunologic targets for pancreatic cancer treatmentXu Zhou, Christoph Springfeld, Susanne Roth, et al.Gastroenterologie Clinique Et Biologique|May 22, 2003
[Frequency of CFTR gene mutations in idiopathic pancreatitis]Frédérique Maire, Thierry Bienvenu, Angèle Ngukam, et al.Pageof 63